Texas Orthopedic Surgeon Michael Taba Accused in $100M Prescription Kickback Scheme
DOJ accuses Texas orthopedic surgeon Michael Taba of a $100M healthcare fraud for taking bribes to prescribe unnecessary medications — impact and prevention.
Page views: 2
A shocking healthcare fraud case in Texas has put the spotlight on prescription kickbacks and the vulnerability of the healthcare system. According to the U.S. Department of Justice, 61-year-old orthopedic surgeon Michael Taba orchestrated a scheme that drained more than $100 million from Medicare and other payors by accepting bribes and kickbacks from pharmacy owners.
Prosecutors say the criminal conduct occurred between May 2014 and March 2017, when Taba allegedly prescribed medically unnecessary medications in exchange for payments from pharmacies. The DOJ alleges those unlawful payments led to a flood of unnecessary prescriptions, driving up costs and exposing patients to needless treatments. This alleged scheme underscores how healthcare fraud and pharmacy fraud can undermine patient safety and inflate insurance premiums.
Beyond the headline dollar figure, the case highlights broader consequences for the healthcare system. When clinicians accept illicit inducements, it erodes public trust, increases out-of-pocket costs for patients, and burdens taxpayers who fund federal health programs. Cases like this often trigger increased scrutiny by regulators, stronger compliance reviews by hospitals and insurers, and tougher enforcement by federal authorities.
To prevent similar medical fraud and prescription kickback schemes, healthcare organizations should reinforce compliance programs, conduct regular auditing of prescribing patterns, and educate staff on red flags such as unexplained relationships with pharmacies. Insurers and pharmacy benefit managers can also deploy data analytics to detect abnormal prescribing trends and rapidly investigate suspicious billing activity.
Patients play a role too: ask why a medication is prescribed, request generic alternatives when appropriate, and review pharmacy choices. Transparency and open communication between patients and providers reduce the chance that unnecessary medications are prescribed without informed consent.
The Department of Justice’s action against Michael Taba serves as a reminder that law enforcement is watching prescription fraud closely. As investigations proceed, healthcare providers, pharmacies, and payors must prioritize ethical practice and robust oversight to protect patients and stem the costly tide of healthcare fraud.
Published on: February 28, 2026, 11:03 am
